Tuvatexib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTuvatexib
Drug Alias NameVDA-1102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHexokinase inhibitorsKeratinocytes modulatorsVoltage-dependent anion channels modulators
TargetsHexokinaseVoltage-dependent anion channels
Therapy Area/IndicationsKeratosis, Actinic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVidac Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVidac Pharma
Active IndicationsN/A
Inactive IndicationsKeratosis, Actinic

Other Information

ATC CodeN/A
Related LinksN/A